ResearchNet - RechercheNet

Table of Contents

• Description
• Objectives
• Eligibility
• Guidelines
• Review Process and Evaluation
• How to Apply
• Contact Information
• Sponsor Description
• Additional Information

Description

While Canada is a diverse country, academic data shows its science and medicine faculties are less diverse than the students and trainees in these programs.^1,2,3 In addition to the diversity gap, gaps in equity and inclusion in Canada's academic and health system institutions continue to create barriers to the hiring, advancement, health, and livelihood of individuals from underrepresented^a groups.^4,5,6,7,8 Underrepresentation is especially evident using an intersectional lens.^b

The transition from trainee to faculty member is a major attrition point,^9,10,11 particularly for individuals from underrepresented groups in Canada,^{12,13,14,15,16,17} that perpetuates a lack of diversity in academic faculty and leadership. Academic career pathway simulation data shows that faculty diversity is increased as more postdoctoral candidates from underrepresented groups successfully transition to faculty positions.¹⁸ More diverse teams can offer more creative and productive scientific innovations than more homogeneous ones,^19,20,21,22 and racial diversity has been shown to have the strongest correlation with scientific impact.²³ Diversity also improves the performance of senior leadership teams.^24,25,26

The first launch of the CIHR Research Excellence, Diversity, and Independence (REDI; pronounced "ready") Early Career Transition Award (2022) will facilitate the transition of promising researchers who self-identify as Black^c (any gender) or racialized^d women^e into independent research faculty positions in Canadian academic, health system and research institutions. Applicants may be post-doctoral researchers, clinicians, or research associates. Racialized women and Black people are among the most underrepresented in science and medicine faculties in Canadian academic institutions,^27,28,29 have the highest unemployment rates compared to non-racialized professors,³⁰ and encounter systemic barriers, discrimination, and inequity within academia.^{31,32,33,34,35}

The CIHR REDI Award Program aligns with Government of Canada and Tri-agency priorities to address systemic racism, sexism, and discrimination in Canadian institutions through an intersectional lens,^36,37,38 tackle systemic barriers that limit the full participation of all talented individuals,³⁹ and increase equitable and inclusive participation in the research system.⁴⁰ It also reflects the commitment of CIHR^41,42 and partners to foster a more equitable, diverse, and inclusive research funding system.

CIHR plans to relaunch this program in future years with each round of CIHR REDI Early Career Transition Awards open to specific underrepresented groups, recognizing existing inequitable systems produce different impacts and outcomes for different groups of people. Future competitions will benefit from the early learnings of the 2022 funding opportunity, community consultations, and the continued accrual of self-identification data from Canadian academic, health systems and research institutions.

CIHR REDI Award Program: Phases, Mentorship and Career Development

The CIHR REDI Award Program is intended to foster the development of independent research scientists who can establish and sustain strong, independent research programs in academia.

CIHR and partners will host a CIHR REDI Forum for awardees every 2 years, providing the opportunity for networking, sharing of research aims and outputs, and career development. The CIHR REDI Forum will be expanded as future cohorts enter the program.

The Award has two phases across a maximum of 6 years.

• The mentored Phase 1 includes a research allowance, stipend, mentorship, and career development. Applicants will propose a Research Project that they will work on in Phase 1. This project will establish the foundation for their independent research program as faculty members in Phase 2. Applicants must work with their Primary Mentor (see Eligibility Criteria for definition) to develop Mentorship and Career Development Plans and identify how they will distinguish their proposed research project from their Primary Mentor's research program (see Information Letter on the Primary Mentor Role [REDI 2022] and FAQ for more details).
• The independent Phase 2 includes a research allowance, salary support, faculty mentorship, and 1:1 matching of funds from the host institution. Awardees are expected to transition to an independent research faculty position – marking the start of Phase 2 – within 2 to 3 years of the funding start date (extensions and accommodations, for example for parental leaves or people with disabilities, will be considered on a case-by-case basis).

For more information regarding the key elements of each phase, please consult the FAQ page.

Research Areas

This funding opportunity will support projects relevant to the following research areas:

• General Funding Pool: will support eight applications that focus on health-related research across CIHR's mandate (includes research to advance fundamental or applied knowledge, health research, health care, health systems, population and public health and/or health outcomes).

In addition to the General funding pool, partners have allocated funding to applications that meet their respective relevant research areas highlighted under Additional Information in the section Research Areas Covered by Specific Funding Pools.

Funds Available

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or be decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to awards received as a result of this funding opportunity.

• The total amount available for the 2022 funding opportunity for Phase 1 and 2 is $28,380,000 (CIHR investment of $24,420,000 and partner contributions of $3,960,000), enough to fund approximately forty-three (43) awards. This amount may increase if additional funding partners participate. (Updated: 2023-04-24)
  • Of this $28,380,000: (Updated: 2023-04-24)
    • $5,280,000 is available to fund eight (8) awards relevant to the General funding pool.
    • $660,000 is available to fund one (1) award relevant to the Aging Person in an Aging Society funding pool.
    • $660,000 is available to fund one (1) award relevant to the Arthritis funding pool; jointly funded by CIHR with the Arthritis Society Canada. (Updated: 2023-04-13)
    • $2,640,000 is available to fund four (4) awards relevant to the Brain Health and Cognitive Impairment funding pool; these awards will be jointly funded by CIHR and with the Alzheimer Society of Canada, the Azrieli Foundation and BrightFocus Foundation.
    • $660,000 is available to fund one (1) award relevant to the Cancer funding pool. (Updated: 2023-01-10)
    • $660,000 is available to fund one (1) award relevant to the Eye Diseases funding pool; jointly funded by CIHR, BrightFocus Foundation and Fighting Blindness Canada.
    • $1,320,000 is available to fund two (2) awards relevant to the Health Systems funding pool; one award will be funded by CIHR and one award will be jointly funded by CIHR with the Azrieli Foundation.
    • $6,600,000 is available to fund ten (10) awards relevant to HIV/AIDS and STBBI funding pool.
    • $660,000 is available to fund one (1) award relevant to Human Development, Child and Youth Health funding pool.
    • $2,640,000 is available to fund four (4) awards relevant to Infectious Disease and Immune System funding pool.
    • $660,000 is available to fund one (1) award relevant to the Kidney Health funding pool; this award will be jointly funded by CIHR with the Kidney Foundation of Canada. (Updated: 2023-04-13)
    • $660,000 is available to fund one (1) award relevant to the Musculoskeletal Health funding pool.
    • $1,320,000 is available to fund two (2) awards relevant to the Pandemic Preparedness and Health Emergencies funding pool.
    • $1,980,000 is available to fund three (3) awards relevant to Rare Diseases funding pool; one award will be jointly funded by CIHR with the Azrieli Foundation.
    • $660,000 is available to fund one (1) award relevant to the Women's Health funding pool. (Updated: 2023-02-03)
    • $1,320,000 is available to fund two (2) awards relevant to the Type 1 Diabetes funding pool; these awards will be jointly funded by CIHR with JDRF Canada. (Updated: 2023-04-24)
• Regardless of how long the Nominated Principal Applicant (NPA) spends in Phase 1, the maximum amount per award is $660,000 for up to six (6) years funded through two specific Phases*:
  • At Phase 1, the maximum amount per award is $90,000 per year for up to three (3) years, for a total up to $270,000 per award.
    • $20,000 per year for the research allowance; and
    • $70,000 per year for the stipend.
  • For information about the maximum amount at Phase 2, please refer to the Supplementary Information for Phase 2 of the CIHR REDI Early Career Transition Award.

For more information on the appropriate use of funds, refer to Allowable Costs.

Objectives

The specific objectives of this funding opportunity are to:

1. Promote research independence and academic research career readiness of highly qualified post-doctoral researchers, clinicians and PhD-holding research associates belonging to specific underrepresented groups;
2. Increase the number of funded researchers from specific underrepresented groups conducting excellent research who secure their first independent research faculty position in a Canadian academic, health system or research institution; and
3. Provide funded researchers from specific underrepresented groups with early career support to enhance their probability of future success in obtaining independent research funding and launching successful research faculty careers in Canada that will contribute to the creation and/or use of health-related knowledge to improve the health of Canadians.

Eligibility

CIHR's position on equity, diversity, and inclusion (EDI) is available in the Tri Agency Statement on Equity, Diversity and Inclusion.

For an application to be eligible all the requirements stated below must be met:

1. The NPA must self identify with at least one of the following groups:
   • Racialized* women
   • Black people
     Note: In relation to these criteria, eligibility will be determined using the response(s) provided in the Equity, Diversity and Inclusion Self-identification Questionnaire. Given that this Funding Opportunity is only open to specific populations, selecting "I prefer not to answer" to one or more of the questions relating to these criteria will prevent your candidacy from being considered. For additional information, please see the FAQ.
   Note: *In this funding opportunity, the term "racialized" is used as an alternative to "visible minorities," as used in the Employment Equity Act and the Equity, Diversity and Inclusion Self-identification Questionnaire.
2. The NPA must be a trainee by the Funding Start Date and, specifically, one of the following:
   • A PhD-holding post-doctoral researcher at a CIHR eligible academic institution, health system or research institution.
   • A clinician holding an MD, DVM, DDS or a PhD or equivalent doctoral degree-holding allied health professional in either a post-doctoral position, or a faculty position denoting independence in clinical responsibilities but not in research, at a CIHR eligible academic institution, health system or research institution.
   • A research associate or equivalent who is a PhD-holding researcher employed at a CIHR eligible academic institution, health system or research institution.
   Note: For the purposes of this funding opportunity, the NPA cannot hold, or be on leave from, an independent researcher position. NPAs who are uncertain of their eligibility as it relates to their employment or appointment (e.g., those with a PhD or equivalent research doctoral degree who are not in a post-doctoral training position at the time of application) are strongly encouraged to email CIHR Contact Centre at support-soutien@cihr-irsc.gc.ca to confirm their eligibility as a trainee prior to preparing their application.
3. The NPA can be a Canadian citizen*, permanent resident*, or a citizen of another country**.
   Notes:
   *NPAs with Canadian citizenship or permanent residency are eligible to hold their Phase 1 awards outside or inside Canada, except for applicants to the Arthritis Pool who MUST hold their Phase 1 awards in Canada. For Phase 2, refer to the Supplementary Information for Phase 2 of the CIHR REDI Early Career Transition Award. (Updated: 2023-04-13)
   **NPAs who are neither Canadian citizens nor permanent residents are only eligible to hold their Phase 1 award in Canada.
4. The Primary Mentor must be an independent researcher with an academic appointment and be either the NPA's current supervisor or a principal investigator who will function as the NPA's Primary Mentor for their Phase 1 REDI project. Additional mentors do not need to hold an academic appointment.
5. The NPA must have successfully completed one of the sex- and gender-based analysis online training modules through the CIHR Institute of Gender and Health. A Certificate of Completion must be included in the application (see How to Apply). Select and complete the training module most applicable to your research project.
6. For applications focusing on Indigenous Health and/or involving Indigenous Peoples:
   • the NPA must provide evidence of having meaningful and culturally safe involvement with Indigenous Peoples (see How to Apply).
   • the Primary Mentor must self-identify as Indigenous (First Nations, Inuit or Métis) and/or provide evidence of having meaningful and culturally safe involvement with Indigenous Peoples (see How to Apply).

Guidelines

General CIHR Policies

Before submitting an application to this funding opportunity, applicants should review the relevant policies and guidelines on the CIHR Funding Policies page to ensure understanding of their responsibilities and expectations.

CIHR Allowable Costs

Applicants should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Guide on Financial Administration (TAGFA) to determine if an expenditure is an appropriate use of grant funds.

To further clarify, the following expenses are examples of appropriate use of the research allowance portion of the award funds, provided they satisfy the principles and pertinent directives of the TAGFA:

• Expenses related to travel and accommodation required for the NPA to attend meetings directly related to the project, including the CIHR REDI Forum; or expenses related to enable virtual meetings where travel is not feasible or recommended.
• Fees associated with professional development training.
• Expenditures that respect the culture and traditions of Indigenous peoples, where needed for the meaningful conduct of research. See TCPS 2 - Chapter 9 Research Involving the First Nations, Inuit and Métis Peoples of Canada and TAGFA Directive on Gifts, Honoraria and Incentives. These include:
  • Costs related to community mobilization and engagement, including culturally relevant promotional items such as, tobacco, cloth, feasting and gift giving for honoring ceremonies, and cash reimbursements (in a method acceptable to the individual or community being reimbursed) to compensate community participation.
  • Contracts and/or consultant fees for knowledge translation and communication activities for Indigenous Elders, community members, and Indigenous Knowledge Keepers involved in activities related to the Indigenous community.
• Costs associated with engaging diverse communities relevant to the research or knowledge mobilization plan (e.g., community mobilization and engagement of racialized or Black communities).
• Expenses related to disability accommodations considered necessary for the NPA to carry out the project, provided the accommodation is not already provided by the administering institution

Use of Personal Information

• Personal information submitted during the application process, including but not limited to information provided through applicant CVs, the Equity, Diversity and Inclusion Self-identification Questionnaire and other application documents required by this FO, will be made available to CIHR personnel for the purposes of future program design and delivery, results measurement and reporting. For further information about the self-identification questionnaire and the use of personal information, see the Equity, Diversity and Inclusion Self-identification Questionnaire Frequently Asked Questions.
• For this funding opportunity, personal information will also be used to determine eligibility of the applicants. Refer to the Eligibility section for details.
• The NPA must submit all reports to CIHR and the partners contributing to their award. CIHR will share reports with partners contributing to the NPA's award should the partners request them (see Conditions of Funding).

Conditions of Funding

• Successful NPAs must begin their award on the Funding Start Date. If this is not possible due to unexpected circumstances, the NPA must make a request to CIHR as soon as possible to defer the award. Requests will be considered on a case-by-case basis.
• For NPAs applying for post-doctorate-level funding, awards will only begin upon successful confirmation to CIHR that the recipient has completed all the requirements of the PhD program (including the oral examination).
• For Canadian NPAs who are seeking to hold their award outside of Canada, the award will only begin after the following documents have been provided to CIHR:
  • proof of Canadian Citizenship or Canadian Permanent Residency; and
  • proof of appropriate visa (e.g., study, work, etc.) to enter the foreign country.
• For NPAs who are not Canadian citizens nor Canadian permanent residents, awards will only begin after proof of an appropriate entry visa (e.g., study, work, etc.) into Canada has been provided.
• Reporting:
  • The CIHR Institute of Infection and Immunity (III) and partners seek to collect information on the outputs, outcomes, and knowledge mobilization activities of this funding opportunity as part of their commitment to evaluate the impact of their investments and benefits to their research communities, and to help guide the improvement of future programs and initiatives. As such, the NPA must submit:
    • Annual brief written progress updates in those years that other formal reports, defined below, are not being submitted.
    • A 2-Year Progress Report that summarizes the outcomes (e.g., related to research, mentorship, and career development), describes how the research allowance portion of the award funds have been used to date, and include the Primary Mentor's assessment of the progress achieved towards the NPA's Mentorship and Career Development Plans.
    • Progress updates (e.g., presentation) at the CIHR REDI Forums to be held every 2 years.
    • A Transition Report, at least 2 months prior to the transition to Phase 2. Information on the Transition Report and the Final Report is found in the Supplementary Information for Phase 2 of the CIHR REDI Early Career Transition Award.
  • Notes:
    • All report templates will be made available to the NPA at the beginning of the funding period and can be filled in as research progresses.
    • Annual and 2-Year Progress Reports are due within 2 months of the anniversary of the award start date.
  • In addition to the above, the NPA may be required to contribute, if requested, to the monitoring, review, and evaluation of the CIHR REDI program, which may include participating in verbal updates, evaluation studies, surveys, workshops, audits, and/or by providing data or reports as required for the purpose of collecting information to assess progress and results.
• The applicant must consent to the use and disclosure of full application and nominative information at the time of application, for purposes of program administration, for purposes of relevance review and/or funding decisions by the relevant sponsors.
• CIHR and partners require that their contribution to your research projects be acknowledged in all written and oral presentations of your research results, including scientific articles, news releases, news conferences, public lectures, and media interviews.
• Data related to research by and with First Nations, Inuit, Métis or Urban Indigenous communities whose traditional and ancestral territories are in Canada must be managed in accordance with data management principles developed and approved by those communities, and on the basis of free, prior and informed consent. This includes, but is not limited to, considerations of Indigenous data sovereignty, as well as data collection, ownership, protection, use, and sharing.
• Applicants are required to reserve and allocate travel costs in their Phase 1 budget for up to two trips within Canada to attend the two-day CIHR REDI Forums. The first Forum is anticipated in Spring 2024 and will then be held every 2 years. See Budget Information for Phase 1.
• NPAs who are successful in this competition are strongly encouraged to actively participate in peer review, and as members of the CIHR College of Reviewers, when invited.
• The NPA can only hold one federally funded training/salary/Chair award at a time (see CIHR Application Administration Guide).
  • Phase 2 Conditions: Refer to the Supplementary Information for Phase 2 of the CIHR REDI Early Career Transition Award.

Review Process and Evaluation

Relevance Review Process

CIHR and partner organizations involved in this funding opportunity will perform a relevance review to identify applications that are in alignment with the objectives and research areas of this funding opportunity. The Summary and Relevance Form are used to determine relevance to the General Pool and any selected Funding Pool(s). Applicants must ensure these documents include the required information for an accurate relevance review.

Applications that are not deemed to be relevant to the General Pool will be withdrawn from the competition.

Review Process

Peer review will be conducted in accordance with the Review guidelines – Priority driven initiatives.

For information on CIHR's peer review principles, see the Peer Review: Overview section of CIHR's website.

Evaluation Criteria

To support the strategic objectives of the CIHR REDI Program and ensure applications align with these objectives, the following evaluation criteria will be used:

• Experience, Training and Contributions
  1. Extent to which the NPA's prior research and training experience, track record and contributions support their potential to transition to an independent research faculty position within their proposed timeline.
• Career Goals and Career Development Plan
  1. Extent to which the description of the NPA's career goals is clear and robust.
  2. Extent to which the NPA's career development plan will effectively enhance their research training and professional development and support their timely transition to an independent research position.
• Research Approach
  1. Extent to which the proposal responds to the objectives of this funding opportunity.
  2. Extent to which the proposed research addresses an important problem or critical barrier to progress in the field relevant to the NPA's area of research.
  3. Potential for the research to advance fundamental or applied knowledge, health research, health care, health systems and public health and/or health outcomes.
  4. Clarity of the rationale and appropriateness of the research design, methods, and analysis for the proposed research.
  5. Extent to which the research proposed for Phase 1 lays a foundation for the research proposed for Phase 2 and their future independent research program.
  6. Extent to which the research proposed in Phase 1 will support the research and technical skills described in the career development plan.
  7. Appropriate identification of difficulties that may be encountered in the research and plans for managing them.
  8. Extent to which the NPA demonstrates their plans to implement knowledge mobilization (KM) strategies.
  9. For applications focusing on Indigenous Health and/or involving Indigenous Peoples (First Nations, Inuit, and/or Métis) the following criteria will also be considered:
     • Description of how the research project will address the rights of Indigenous Peoples and the self-determination and self-governance of Indigenous Peoples, such as following the First Nations Principles of OCAP® [5] (Ownership, Control, Access and Possession), or other principles of Indigenous self-determination, as appropriate; and
     • Demonstration of the extent to which the NPA will ensure that the research is conducted by, grounded in, or engaged with First Nations, Inuit or Métis communities, societies or individuals and their wisdom, cultures, experiences or knowledge systems, as expressed in their dynamic forms, past and present.
• Mentorship Plan
  1. Extent to which the Mentorship Plan is anticipated to promote the NPA's independence and increase the likelihood they will transition to an independent research position within the proposed timeline.
  2. Extent to which culturally responsive mentorship and an intersectional understanding of equity, diversity and inclusion considerations, principles and practices inform the plan.
• Equity, Diversity, and Inclusion
  1. Quality and appropriateness of the NPA's plans to incorporate equity, diversity, and inclusion into:
     • The research proposed in their REDI application, and
     • Their research program when they become an independent researcher.
  2. Extent to which the Phase 1 Host Institution is committed to providing an appropriate, equitable, inclusive, and accessible environment for the NPA's research and professional development.
  Note: Accommodations to the NPA's transition timeline, for example for parental leaves and people with disabilities, should be considered.

Funding Decision

CIHR-Institutes and partner organizations will receive the funding scenarios which contain the list by ranking, the rating and term of the award that have been determined to be relevant to the objectives of the initiative and fall in the fundable range.

Applications relevant to each pool will be funded top down in rank order. If a pool is undersubscribed or lacks fundable applications, funds may be rolled into another specific pool or to the general funding pool. Remaining applications will be pooled together in the General pool and funded in rank order.

All funding decisions will be made to maximize funding per pool allocation while respecting rank order and relevancy for all fundable applications.

Applications that receive a rating below 3.5 will not be funded.

The names of successfully funded applicants will be published on the CIHR website and via partner's communication channels.

Partner and Internal Collaborator Participation

The opportunity to add new partners and internal collaborators to this funding opportunity may arise after publication. These partners and internal collaborators may not be listed; however, the principles that govern relevance review, including consent to share information and funding decisions, will still apply.

How to Apply

• The application process for this funding opportunity is comprised of one step: Full Application
• To complete your Full Application, follow the instructions in the Training Awards - ResearchNet "Application" Instructions as applicable, along with any additional instructions found below under "Specific Instructions".
• All participants listed are required to:
  • Have/obtain a CIHR PIN
  • Complete the Equity, Diversity and Inclusion Self-Identification Questionnaire.

Specific instructions to complete your ResearchNet application

Notes:

• Please ensure that your application is complete (includes all required signatures) and is submitted on time to CIHR. Note: CIHR cannot legally accept an application until the "Consent and Submit" task is completed on ResearchNet.
• Applicants must adhere to requirements for formatting and attachments. Failure to comply with these requirements may negatively impact the evaluation of the application and can lead to withdrawal of an application.

Step 1 - Application

Task: Identify Participants

• The NPA and Primary Mentor* must be identified, at a minimum (see Eligibility to ensure all requirements are met).
• The NPA and Primary Mentor must submit a CIHR Academic CV.
  • The NPA and Primary Mentor are invited to include in their CIHR Academic CCV, under section "Employment" any special considerations that have had an effect on the NPA’s and Mentor’s track records that explains any variations in the chronology of their academic experience, for example, health problems (including physical and mental), family responsibilities, disabilities, leaves of absences, diverse career paths, trauma and/or loss, pandemic impact or other circumstances. (Updated: 2023-02-03)
• Up to five (5) additional mentors* may be identified, including individuals who do not hold an academic appointment.
  • Academic mentors must attach a CIHR Academic CV.
  • Mentors who do not hold an academic appointment must attach an Applicant profile CV (maximum three pages).
• Provide degrees held by the NPA: PhD, MD, DVM, DDS. Research Associates (or equivalent) or allied health professionals are required to hold a PhD or equivalent doctoral degree.
  *Note: In ResearchNet, the Primary and Additional Mentors will be identified in the role of "Primary Supervisor" and "Supervisor", respectively. However, consistent with this funding opportunity, these individuals will be identified as Primary and Additional Mentors within your Proposal.

Task: Enter Proposal Information

• The Proposal must address all five evaluation criteria. Note that the Proposal should be organized using specific headers (see below). Applicants are expected to work with their Primary Mentor to prepare the application. See the Information Letter on the Primary Mentor Role for more information.
• Applicants submitting Proposals written in French will be allowed to submit additional pages, based on evidence that French documents require approximately 20% more space than similar English documents. Therefore, the following page limits will apply:
  • Ten (10) pages when the Proposal is written in English.
  • Twelve (12) pages when the Proposal is written in French.
  • This includes charts, tables, figures, and photographs, but excludes references.
    Note: Any pages exceeding the specified page limits above will be removed prior to peer review, with no further notification to the Nominated Principal Applicant.
• The Proposal should include the following headings (applicants should refer to the FAQ for additional guidance for each section):
  • Label section as: Experience, Contributions and Career Development
    1. Describe your potential to develop into a successful, independent researcher.
    2. Describe your prior research, training experiences and contributions, and how you will benefit from the additional mentorship and career development proposed in your application to become an independent researcher.
    3. Describe your current and long-term scientific and professional career goals.
    4. Provide a tailored career development plan and timeline (with milestones) for obtaining the research experience, training and career development needed to launch a successful independent research career.
  • Label section as: Proposed Research
    1. Propose a research plan that addresses both Phase 1 and Phase 2, and clearly indicate the research planned for each phase of the REDI award.
    2. Describe the relationship between your proposed research and your Primary Mentor's research program, and how you will distinguish your research program from that of your Primary Mentor and achieve independence.
    3. Include a plan for knowledge mobilization (KM), which may include integrated approaches to KM and inclusive methods such as co-production and mobilizing different types of knowledge (where relevant), to inform practice, policy, communities, and further research, as appropriate to your area of research, career stage and health profession (if applicable). This may include how you will build a network with the community you plan to work with (if applicable).
  • Label section as: Mentorship Plan
    1. Co-develop the plan with your Primary Mentor/additional Mentors, as applicable.
    2. Provide a plan that is clear, specific, and robust; tailored and appropriate to your training needs, career goals and research area/pillar; and aligned with your research and career development plans.
    3. Use mentoring tools (e.g., mentoring compacts, individual development plans) and incorporate elements of culturally responsive mentorship and an intersectional understanding of equity, diversity and inclusion considerations, principles, and practices.
    4. Describe the space, facilities, personnel, and other support available for the research project, educational and training opportunities.
  • Label section as: Equity, Diversity, and Inclusion
    1. Include your plans to: (1) incorporate equity, diversity, and inclusion into your proposed research; and (2) build a diverse and inclusive research team and environment when you establish your independent research program.

Notes:

• The Proposal should stand alone (i.e., it should contain all the information required to permit peer reviewers to evaluate all four sections of your Proposal).
• References can be attached in a Research Proposal Appendix.

Task: Attach Other Application Materials

• Upload the following documents provided by the Primary Mentor:
  • Letters of Support (mandatory) - Upload under "Letter of Support from Primary Mentor" (maximum two [2] pages) which must include:
    • A description of the Mentor's area(s) of expertise and their role in the mentorship of the NPA.
    • An overall assessment of the applicant, including their research performance and/or clinical training, and their potential to transition to an independent research position within the timeline proposed in their REDI application.
    • Statements that the Mentor is committed to:
      • Supporting the execution of the Research Proposal, Mentorship and Career Development Plans, as appropriate to their mentorship role.
      • Recognizing the importance of reconciliation with Indigenous Peoples, bias awareness, anti-racism, anti-ableism, and gender equity, among other principles in increasing the effectiveness of their mentorship role.
      • Aiming to apply principles of culturally responsive mentorship and intersectional EDI consideration in their mentorship approach (see Additional Information).
      • Contributing to a joint assessment by the NPA and Primary Mentor that will be part of the Two-Year Progress Report and Transition Report. This will include the NPA's assessment of their progress and the achievement of major milestones, and the Primary Mentor's assessment of their contributions to the NPA's career development, and alignment of achievements with the Mentorship and Career Development Plans.
  • A Letter from the Host Institution (i.e., Dean or appropriate authority) (maximum two [2] pages) describing its commitment to equity, diversity, and inclusion and outlining examples of efforts taken to make research environments inclusive, accessible, safe, and supportive for the applicant's research and professional development.
  • Letter of Support from each Additional Mentors [mandatory if applicable] (maximum one [1] page). This letter should describe the role of the mentor in the Mentorship and Career Development Plans and how they will work with the other Mentors to support the execution of the plan (as appropriate). NPAs who have identified additional mentors must submit a letter of support from each additional mentor.
• Other – Upload the following under "Other" – Label each document as indicated below in bold when uploading into ResearchNet:
  • Certificate of Completion for the SGBA Modules (mandatory) -. upload with description "Certificate of Completion for the SGBA modules":
    •  After completing the appropriate sex- and gender-based analysis training module(s) you will receive a certificate of completion that you will save and upload here.
    • N.B. The certificate is issued as a secured document; however, to successfully append the document to your application, you must upload an unsecured PDF copy. The certificate can be saved as an unsecured PDF by using print screen or by scanning the document.
  • Letter Confirming Not an Independent Researcher ( mandatory for  clinician NPAs or other NPAs holding a faculty appointment) — A letter from the Dean or appropriate authority must confirm that the NPA is not considered to be an independent researcher (maximum one [1] page). Upload with description "Letter Confirming Not an Independent Researcher"
  • Indigenous Experience-Name (mandatory for all research involving Indigenous Peoples)- Upload with description "Indigenous Experience-Name":
    • This funding opportunity seeks applicants and Mentors who can demonstrate their experience working in an Indigenous Health Research environment, which may include Indigenous living experience, addressing power imbalances and cultural safety. The NPA must therefore submit a one (1) page attachment describing how they or a team member meets this requirement.

Task: Download Supplemental Application Information

• Phase 1 Budget Confirmation (mandatory): To present the budget for Phase 1 of the Award, the NPA must submit a Budget for Phase 1 (free form budget) and upload with the description "Phase 1 Budget Confirmation". Applicants must include costs for a minimum of 1 to 2 trips within Canada to attend the CIHR REDI Forums.

Task: Complete Peer Review Administration Information (optional)

• You are encouraged to suggest reviewers that you feel have the expertise to review your application. CIHR reserves the right to make the final selection of external reviewers. You should not suggest reviewers in conflict of interest. Consult the Conflict of Interest and Confidentiality Agreement for Peer Reviewers and Peer Review Observers on the CIHR website for more information.
• You also have the option to exclude reviewers by providing the names of individuals that you feel cannot provide an objective review of your application.

Task: Apply to Priority Announcements/Funding Pools (optional)

• Those applying to a specific research area must select the appropriate Funding Pool under the "Priority Announcement/Funding Pool Title" drop-down list, then select the funding pool under the "List of Relevant Research Areas" drop-down list, and then press "Save".
• You may select up to three (3) funding pools for your application.
• Complete the Relevancy:
  • Applicants must explicitly identify (i) which of the selected funding pools should be considered as their first choice and (ii) how their application directly aligns with each of the funding pool(s) selected (half-page for each selection).
• If applying to the Arthritis Funding Pool: Awards must be held in Canada to receive funding from Arthritis Society Canada. (Updated: 2023-04-13)

It is not necessary to make a selection to be considered for the General Pool.

Task: Print, Scan and Upload Signature Pages

• Signatures must be included for all participants (except Collaborators), and individual(s) with signing authority from the Institution Paid.
• Original signatures are not required. The scanned signed signature pages and the Routing Slip must be uploaded in the Print/Upload Signature Pages task in ResearchNet prior to submitting your application.

Contact Information

For all inquiries, please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
Email: support-soutien@cihr-irsc.gc.ca

For service hours, please consult our Contact us page.

Sponsor Description

Notes: Additional partners/internal collaborators, including from industry and the private sector, may join this funding initiative over the coming year.

Partners

Alzheimer Society of Canada
The Alzheimer Society of Canada (ASC), at national, provincial and local levels, forms a nationwide network of services to help Canadians affected by Alzheimer Disease. The Society provides Research Grants and Training Awards to support Canadian investigators conducting biomedical research into causes and a cure for Alzheimer Disease, and research into social and psychological aspects of Alzheimer Disease, including caregiving, family support and long-term care.

Arthritis Society Canada (Updated: 2023-04-13)
Arthritis Society Canada’s mission is to fight the fire of arthritis with research, advocacy, innovation, information, and support. Arthritis Society Canada’s research investments will deliver better health outcomes for people affected by arthritis by prioritizing:

• Innovative research informed by patient priorities, and
• Supporting a pipeline of strong researchers.

Impact areas of focus are related to pain, osteoarthritis, inflammatory arthritis, childhood arthritis and work. More details can be found in Accelerating Impact Research Strategy 2020-2025.

The Azrieli Foundation
The Azrieli Foundation is a federally registered Canadian foundation which funds institutions as well as operates programs in Canada and in Israel. The Foundation supports scientific and medical research, higher education, Holocaust education, youth empowerment and school perseverance, music and the arts, architecture and quality of life initiatives for neurodiverse people.

BrightFocus Foundation
BrightFocus Foundation funds exceptional scientific research worldwide to defeat Alzheimer's disease, macular degeneration, and glaucoma and provides expert information on these heartbreaking diseases.

Fighting Blindness Canada
Fighting Blindness Canada (FBC) is the largest charitable funder of vision research in Canada. We offer hope to Canadians by funding the best, most promising research that is driving treatments and cures for blinding eye diseases.

The Kidney Foundation of Canada (Updated: 2023-04-13)
The Kidney Foundation of Canada (KFOC) is committed to achieving excellent kidney health, optimal quality of life, and a cure for kidney disease. The KFOC’s mission is to eliminate the burden of kidney disease through funding and stimulating innovative research for better treatments and a cure; providing education and support to prevent kidney diseases in those at risk and empower those with kidney disease to optimize their health status; advocating for improved access to high quality care and increasing public awareness and commitment to advancing kidney health and organ donations.

JDRF Canada (Updated: 2023-04-24)
JDRF is a global leader in the search for an end to type 1 diabetes, through both research funding and advocacy. In addition to curing type 1 diabetes, part of their mission is to help those living with type 1 diabetes today to live healthier, easier, and safer lives. Their mission is realized by supporting research in two core areas: Cure T1D and Improve Lives. Breakthrough research, transformative therapies, emerging technologies, translational opportunities, and clinical trials are prioritized.

Internal Collaborators

Canadian Institutes of Health Research
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.

Scientific leadership and support for this initiative is provided by the Institute of Infection and Immunity.

CIHR Institute of Infection and Immunity
The CIHR Institute of Infection and Immunity (III) supports research and helps to build research capacity in the areas of infectious disease and the body's immune system. Through the Institute's programs, researchers address a wide range of health concerns related to infection and immunity including disease mechanisms, disease prevention and treatment, and health promotion through public policy.

CIHR HIV/AIDS and STBBI Research Initiative
The CIHR HIV/AIDS and STBBI (Sexually Transmitted and Blood-Borne Infections) Research Initiative is led by the CIHR Institute of Infection and Immunity (III). The CIHR HIV/AIDS and STBBI Research Initiative (formerly the HIV/AIDS Research Initiative) is responsible for the management and oversight of the research components of the major Government of Canada initiative in HIV/AIDS namely the Federal Initiative to Address HIV/AIDS in Canada. As outlined in the Pan-Canadian STBBI Framework (Reducing the Health Impact of Sexually Transmitted and Blood-Borne Infections in Canada by 2030: A Pan-Canadian STBBI Framework for Action) and Canada's Action Plan on STBBI (Accelerating our response: Government of Canada five-year action plan on STBBI), Canada has adopted an integrated approach to HIV and STBBI across the full continuum of prevention, testing, initiation of care and treatment and ongoing care and support. Consequently, the mandate of the CIHR HIV/AIDS Research Initiative has been expanded to incorporate other STBBI, including but not limited to hepatitis B, hepatitis C, chlamydia, gonorrhea, syphilis, and human papilloma virus.

CIHR Institute of Aging
The CIHR Institute of Aging (IA) supports research to promote healthy aging and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with aging.

CIHR Institute of Cancer Research (ICR) (Updated: 2023-01-10)
The Institute of Cancer Research (ICR) funds cancer research in Canada based on internationally accepted standards of excellence, which bear on preventing and treating cancer, and improving the health and quality of life of cancer patients. CIHR is one of the leading cancer research funders in Canada.

CIHR Institute of Genetics
The CIHR Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries.

CIHR Institute of Gender and Health
The CIHR Institute of Gender and Health (IGH) mission is to foster research excellence regarding the influence of sex and gender on health and to apply these findings to identify and address pressing health challenges facing men, women, girls, boys and gender-diverse people.

CIHR–Institute of Health Services and Policy Research (IHSPR)
The Institute of Health Services and Policy Research (IHSPR) is dedicated to supporting innovative research, capacity building and knowledge translation initiatives designed to improve the way health care services are organized, regulated, managed, financed, paid for, used and delivered, in the interest of improving the health and quality of life of all Canadians.

CIHR Institute of Human Development, Child and Youth Health
The CIHR Institute of Human Development, Child and Youth Health (IHDCYH) invests in research that promotes the best health for all Canadians, from the very start of life. By supporting research to improve reproductive, child, and youth health outcomes, IHDCYH helps young Canadians and families achieve their full potential for ideal growth and development

CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) (Updated: 2023-04-24)
The Institute of Nutrition Metabolism and Diabetes (INMD) supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation of conditions and problems associated with hormone, digestive system, kidney, and liver function.

CIHR Institute of Musculoskeletal Health and Arthritis
The CIHR Institute of Musculoskeletal Health and Arthritis (IMHA) supports research to enhance active living, mobility and movement, and oral health; and addresses causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions related to bones, joints, muscles, connective tissue, skin and teeth.

CIHR Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE)
The Centre for Research on Pandemic Preparedness and Health Emergencies (the Research Centre), which is housed within CIHR, will ensure Canada has an emergency-ready health research system. The Research Centre builds on Canada's research strengths and continues to grow its capacity to be a leader in preventing, preparing for, responding to, and recovering from existing and future pandemics and public health emergencies. It collaborates with other federal departments and agencies, as well as stakeholders domestically and internationally.

Additional Information

Research Areas Covered by Specific Funding Pools

• Aging Person in an Aging Society Funding Pool: will support one application aligned with the Institute of Aging (IA)'s mandate. IA's mandate is the aging person in an aging society, and the effects of different diseases and conditions on aging.
• Arthritis Funding Pool: will support one application from candidates whose research program is grounded in finding the causes and cures of arthritis and promoting the best possible treatments, care and support for those with arthritis. Applications will be considered from candidates in basic science, clinical, health services and/or policy research with projects that align with osteoarthritis, inflammatory arthritis, pain, childhood arthritis or the capacity to work.
• Brain Health and Cognitive Impairment Funding Pool: will support four applications focusing on:
  • understanding the underlying mechanisms leading to the development and acceleration of cognitive impairment for better risk reduction, early detection, management and treatment of cognitive impairment, and/or the mechanisms promoting brain health (biomedical and clinical research);
  • improving care and services for people with cognitive impairment (health system, health economy, epidemiology);
  • developing, evaluating, and implementing strategies to improve the health and wellbeing of informal and formal caregivers (health system, health economy, epidemiology).
  Note: Cognition (the ability to learn, solve problems, remember, and appropriately use stored information) is a key to successful health throughout the lifespan, including aging. Loss of cognitive abilities is one of the most common fears expressed about aging. Many disorders are associated with dementia, including Alzheimer's disease, vascular dementia, frontotemporal dementia, dementia with Lewy Bodies and mixed dementia, all of which can also occur in people with pre-existing neurodevelopmental conditions.
• Cancer Funding Pool: will support one application relevant to the Institute of Cancer Research (ICR)’s mandate to reduce the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation. See our website for more information on the research priorities of ICR. (Updated: 2023-01-10)
• Eye Diseases Funding Pool: will support one application whose area of focus includes neurodegenerative eye diseases including age-related macular degeneration, glaucoma or inherited retinal degenerative diseases (e.g., retinitis pigmentosa, Usher syndrome).
  Note: Vision loss can have a devastating impact on personal quality of life, caregiver support and on the healthcare system, but funding for vision and eye disease research is often lacking. The pool is open to disciplines from molecular and cellular biology through clinical and behavioral health research and may address issues such as the basic mechanisms underlying the eye disease, development of new therapies or the diverse effects eye disease can have on human health and quality of life. Multidisciplinary research plans based on synergizing collaborations and/or multi-pronged projects to investigate the common features of neurodegenerative eye disease are also encouraged.
• Health Systems Funding Pool: will support two applications directly aligned with the Institute of Health Services and Policy Research (IHSPR)'s mandate and that accelerate the discovery/implementation of innovations in how to organize, finance, manage and/or deliver health care services that advance the Quadruple Aim and health equity, in the specific areas of:
  • integration of care (including integrated delivery systems, continuity of care, integration of upstream prevention approaches within health care delivery settings that address the social determinants of health);
  • primary, home and community-based, and/or long-term care;
  • the health care workforce (including funding and remuneration, training and support, interdisciplinary team-based collaboration, strategies to increase the EDI of the workforce);
  • the incorporation of digital health solutions, virtual care technologies (such as e-referral and e-consult), remote monitoring solutions in care delivery models;
  • anti-racist, anti-discriminatory, diverse and inclusive health care delivery systems and/or service delivery models; and/or
  • sustainable health care systems and service delivery models (strategies and actions for the prevention, mitigation, responsiveness to health risk posed by climate change and other environmental impacts).
• HIV/AIDS and STBBI Funding Pool: will support ten applications that align with CIHR HIV/AIDS and STBBI Research Initiative Strategic Plan 2022-2027.
• Human Development, Child and Youth Health Funding Pool: will support one application relevant to the mandate of the Institute of Human Development, Child and Youth Health (IHDCYH). As a lifecycle-based Institute, IHDCYH has a broad mandate that covers defined time periods and a wide range of issues pertaining to human development: pre-conception; fertilization; embryonic and fetal development; the health of the parents; and the health and development of infants, children and youth.
• Infectious Disease and Immune System Funding Pool: will support four applications relevant to the mandate of the Institute of Infection and Immunity (III) and which align with a wide range of health concerns related to infection, immunity, and inflammatory aspects of chronic disease; transcends disciplines and includes but is not limited to disease mechanisms, prevention, and treatment, and public health promotion.
• Kidney Health Funding Pool: will support one application developing their research program directly related to all aspects of kidney function and diseases of the kidney and urinary tract. Research can be from across the four pillars (biomedical, clinical, health systems, population health). Multidisciplinary and collaborative plans are also encouraged. This includes but is not limited to plans focusing on:
  • Understanding development, risk, prevention, treatment, management, care or cure for all aspects of kidney function and diseases of the kidney and urinary tract;
  • Improvement of health systems and services with the goal of improving efficiency and effectiveness of the health care system through changes to practice and policy related to kidney disease;
  • Population and public health research with the goal of improving the kidney health of populations living in Canada through increased understanding of ways in which social, cultural, environmental, occupational and economic factors determine health status.

  Note: Successful awardees in this pool will also be eligible for enrolment in the curriculum component of the KRESCENT program . To learn more about this program please contact KFOC directly. (Updated: 2023-04-13)

• Musculoskeletal Health Funding Pool: will support one application relevant to the Institute of Musculoskeletal Health and Arthritis research priorities:
  • Active living, mobility and the wide range of conditions related to bones, joints, muscle, connective tissues, skin as well as the mouth, teeth and craniofacial region.
  • Applications will be considered from candidates in basic science, clinical, health services and/or policy research.
• Pandemic Preparedness and Health Emergencies Funding Pool: will support two applications relevant to the mandate of the CRPPHE and that focus on creating knowledge, its translation/mobilization and capacity building in the area of pandemic or health emergency preparedness or response. Applications will be considered from candidates in basic science, clinical, health services and/or policy research. Note: For the purpose of this funding opportunity, a health emergency is defined as: "A present or imminent event or phenomenon, of a temporary, acute nature, with actual or potential significant negative impacts on human health, resulting in:
  • serious disruption of the functioning of a community; and/or
  • the declaration of a state of emergency by a municipal, provincial/territorial, federal and/or Indigenous government, or international organization with a health research mandate; and that
  • requires prompt research action to protect and strengthen human health."
• Rare Diseases Funding Pool: will support three applications focusing on inherited disorders and syndromes with lifespan and health considerations with a focus on health and well-being of patients, caregivers, and families as well as models of integrated care for inherited chronic disease patients with complex needs.
• Women's Health Funding pool: will support one project relevant to the mandate of the Institute of Gender and Health and which aims to use an intersectional lens to improve health and wellness concerns that solely, disproportionately, or differently affect women, girls, Two-Spirit people, and/or people of under-represented gender identities (including but not limited to trans, non-binary, gender fluid, and agender people). Applications across the four pillars of research will be considered. (Updated: 2023-02-03)
• Type 1 Diabetes Funding Pool: will support two applications focused on research relevant to type 1 diabetes (T1D) risk, prevention, diagnosis, management (including strategies for metabolic control and psychosocial interventions), care or cure. Research relevant to kidney, eye or cardiovascular complications of T1D will be also considered relevant. (Updated: 2023-04-24)

Terminology

1. Underrepresented groups: Include, but are not limited to, women, Indigenous Peoples (First Nations, Inuit and Métis), persons with disabilities, members of visible minority/racialized groups and members of 2SLGBTQI+g communities (see the Dimensions Charter for more information). As defined by the Tri-Agency Equity, Diversity and Inclusion Action Plan (2018-2025) and Canada’s First Federal 2SLGBTQI+ Action Plan (2022).
2. Intersectionality: Intersectionality is a Black feminist theoretical framework with origins as early as the 1850s. The term was first coined by Kimberlé Crenshaw in 1989 to name the experiences of Black women who face intersecting and cumulative forms of oppression and discrimination (racism and sexism). An intersectional framework assumes that an individual's experiences are not simply equal to the sum of their parts but represent intersections of axes of social power. For example, the health-related experiences of immigrant women may be different from those of immigrant men and non-immigrant women. In Sex- and Gender-Based Analysis Plus (SGBA+), we discuss intersectionality as an extension of sex and gender analysis, but intersectionality also originates in critical race theory and can be applied across other social identities or positions in society (social positions). Source: CIHR. 2021. Meet the Methods series: Quantitative intersectional study design and primary data collection. Issue 3 Part 1. For more on this concept, see Crenshaw K. Demarginalizing the Intersection of Race and Sex: A Black Feminist Critique of Antidiscrimination Doctrine, Feminist Theory and Antiracist Politics. 1989. University of Chicago Legal Forum. Vol. 1989; Article 8.
3. Black: In this funding opportunity, we define "Black" as those of Black African descent, which includes those who identify as Black Africans, and those found worldwide who identify as descendants of Black African peoples. Source: Canadian Black Scientists Network. 2021. Message from the President. CBSN.
4. Racialized: In this funding opportunity, the term racialized is used as an alternative to "visible minorities," as used in the Employment Equity Act. This definition is consistent withCIHR and Tri-Agency flagship documents such as Dimensions and the NFRF Best Practices in EDI Research. (Updated: 2023-02-03)
5. Woman: The term woman refers to a person who internally identifies and/or publicly expresses as a woman. This may include cisgender and transgender individuals. Cisgender means that one's gender identity is the same as one's sex assigned at birth. A transgender person's identity differs from the sex they were assigned at birth. Sources: CIHR. 2022 . Frequently Asked Questions about the Equity, Diversity and Inclusion Self-identification Questionnaire. Question 12. Canadian Institutes of Health Research.

Hyperlinks for Supplementary Documents

• Frequently Asked Questions (FAQ)
• Information Letter on the Primary Mentor Role (REDI 2022)
• Supplementary Information for Phase 2 of the CIHR REDI Early Career Transition Award (2022)

Additional Resources

1. Tri-agency Equity, Diversity and Inclusion Resources. Includes key resources on information and best practices for EDI and Indigenous Rights, and online training modules for researchers.
2. NSERC Guide on Integrating Equity, Diversity and Inclusion Considerations in Research.
3. San Francisco Declaration on Research Assessment (DORA) which recognizes that scholarly outputs are not limited to published journal articles but can include a broader range of outputs.
4. Health Research Training at CIHR: Training Tools. Includes Professional Development Offerings and Research Training Modules.
5. National Academies of Sciences, Engineering and Medicine. The Science of Effective Mentorship in STEMM. Washington, DC: The National Academies Press. 2019. If interested, an online guide and podcast can also be accessed from this website under Resources at a Glance.
6. Dr. Angela Byars-Winston's talk on Effective, Culturally Responsive Mentorship (Jan. 20, 2022), posted on the Society for the Advancement of Biology Education Research (SABER) website.
7. Center for the Improvement of Mentored Experiences in Research (CIMER). Culturally Aware Mentoring Resources.
8. iBiology Mentor Training to Improve Diversity in Science. Part 1: A Conversation on Culturally Aware Mentoring; Part 2: Resources and Strategies to Enhance Culturally Aware Mentoring.
9. Center for the Improvement of Mentored Experiences in Research (CIMER). Resources – Including Materials for Mentors and Mentees.
10. Project Implicit. Implicit association tests to measure attitudes or beliefs people may be unwilling or unable to report.
11. National Institutes of Health. Research Training and Career Development. Resources - Career Guidance.
12. iBiology Careers – Professional Development Resources.

References

1. University of British Columbia. Diversity and equity in UBC Science Tenure-stream Faculty – Progress Report 2019.
2. Toronto Metropolitan University (previously Ryerson University). Our Community Our Diversity – 2018 Employee Diversity Self-ID Report [ PDF (2.62 MB) - external link ] and 2018 data visualizations for faculty and students. Accessed April 2022.
3. Dalhousie University. Dalhousie Census Report 2020.
4. Henry F et al. The Equity Myth: Racialization and Indigeneity at Canadian Universities.. 2017. UBC Press.
5. Canadian Medical Association. Equity and Diversity in Medicine -Background to CMA Policy. 2019.
6. Acker S, Webber M, and Smyth E. Tenure troubles and equity matters in Canadian academe. Brit. J Soc. Educat. 2012;33:743-61.
7. Mohamed, T. & Beagan, B. L. (2019) 'Strange faces' in the academy: experiences of racialized and Indigenous faculty in Canadian universities. Race Ethnicity and Education.2019;22(3);338-354.
8. Dryden, O. & Nnorom, O. (2021). Time to dismantle systemic anti-black racism in medicine in Canada. CMAJ. 2022;193:E55-57.
9. Edge J, Munro D. Inside and outside the academy: Valuing and preparing PhDs for careers. The Conference Board of Canada; 2015.
10. Jadavji N, et al. The 2016 Canadian National Postdoctoral Survey Report; 2016.
11. Meyers LC et al. Survey of checkpoints along the pathway to diverse biomedical research faculty. 2018. PloS One. 2018;13(1): e0190606.
12. Campos JS et al. Challenging systemic barriers to promote the inclusion, recruitment, and retention of URM faculty in STEM. Cell Host and Microbe. 2021;866.
13. University of British Columbia. Diversity and equity in UBC Science Tenure-stream Faculty – Progress Report 2019.
14. Toronto Metropolitan University (previously Ryerson University). Our Community Our Diversity – 2018 Employee Diversity Self-ID Report [ PDF (2.62 MB) - external link ] and 2018 data visualizations for faculty and students. Accessed April 2022.
15. Dalhousie University. Dalhousie Census Report 2020.
16. Statistics Canada. (2020, September). Survey of postsecondary faculty and researchers. The Daily for Tuesday, September 22, 2020. Survey number 5299.
17. Council of Canadian Academies, 2021. Degrees of Success. Ottawa (ON). The Expert Panel of the Labour Market of PhD Graduates, Council of Canadian Academies.
18. Gibbs KD Jr et al. Decoupling of the minority PhD talent pool and assistant professor hiring in medical school basic science departments in the US. eLife. 2016;e21393.
19. Hong, L. and Page, S. E. Groups of diverse problem solvers can outperform groups of high-ability problem solvers. Proc. Natl Acad. Sci. 2004;101:16385-89.
20. Hofstra B. et al. The diversity-innovation paradox in science. Proc. Natl. Acad. Sci. 2020;117:9284-91.
21. Nielsen, M. W. et al. Opinion: gender diversity leads to better science. Proc. Natl Acad. Sci. 2017;114: 1740-2.
22. Herring, C. Does diversity pay?: race, gender, and the business case for diversity. Am. Sociol. Rev. 2009;74: 208–224.
23. AlShebli BK, Rahwan T and Woon WL. Nat Commun. 2018;9:5163.
24. Hunt, V., Prince, S, Dixon-Fyle, S., & Yee, L. Delivering through diversity. 2018. McKinsey & Company.
25. Catalyst. (2021, November). Women on Corporate Boards (Quick Take). Catalyst.
26. Dixon-Fyle S, Dolan K and Prince S. Diversity Wins. 2020. McKinsey & Company.
27. University of British Columbia. Diversity and equity in UBC Science Tenure-stream Faculty – Progress Report 2019.
28. Toronto Metropolitan University (previously Ryerson University). Our Community Our Diversity – 2018 Employee Diversity Self-ID Report [ PDF (2.62 MB) - external link ] and 2018 data visualizations for faculty and students. Accessed April 2022.
29. Dalhousie University. Dalhousie Census Report 2020.
30. Canadian Association of University Teachers (CAUT). Underrepresented and Underpaid, 2018 and Smith MS, Bray N. Diversity Gap in Canada. University of Alberta. 2018. Accessed Oct. 17, 2022.
31. Henry F et al. The Equity Myth: Racialization and Indigeneity at Canadian Universities. 2017. UBC Press.
32. Canadian Medical Association. Equity and Diversity in Medicine -Background to CMA Policy. 2019.
33. Acker S, Webber M, and Smyth E. Tenure troubles and equity matters in Canadian academe. Brit. J Soc. Educat. 2012;33:743-61.
34. Mohamed, T. & Beagan, B. L. 'Strange faces' in the academy: experiences of racialized and Indigenous faculty in Canadian universities. Race Ethnicity and Education. 2019;22(3):338-354.
35. Dryden, O. & Nnorom, O. Time to dismantle systemic anti-black racism in medicine in Canada. CMAJ. 2021;193:E55-57.
36. Mandate Letter to the Minister of Innovation, Science and Industry. December 2021.
37. Speech from the Throne (2021). Government of Canada.
38. Building a Foundation for Change: Canada's Anti-Racism Strategy 2019-2022.
39. Tri-agency EDI Action Plan for 2018-2025. Accessed July 14, 2022.
40. Tri-agency Statement on Equity, Diversity and Inclusion (EDI). Accessed July 14, 2022.
41. CIHR Strategic Plan 2021-2031 – Action Plan for Year 1 (2021-2022).
42. CIHR's commitment to enhancing equity, diversity, and inclusion in the research funding system - Message from the Vice-President, Research Programs. October 2020.